160 likes | 291 Views
Everyday evidence – therapy outcomes in Swedish public health service settings. SPR 42nd annual meeting Bern, June 31, 2011 Andrzej Werbart & Lars Levin. Background. Dodo bird & Equivalence paradox Empirically supported treatment (EST) Randomized controlled trials (RCT) Pro’s & con’s
E N D
Everyday evidence – therapy outcomes in Swedish public health service settings SPR 42nd annual meeting Bern, June 31, 2011 Andrzej Werbart & Lars Levin
Background • Dodo bird & Equivalence paradox • Empirically supported treatment (EST) • Randomized controlled trials (RCT) • Pro’s & con’s • Evidence based practice in psychotherapy (EBPP) • QAPS
Research questions • To investigate which patients get which treatment – comparing pre-treatment characteristics • Total sample and by therapy type • To compare outcomes from different forms of psychotherapy (CBT, PDT, INT) • Replication of prior studies (CORE) • To investigate whether different measures capture different aspects of change
Method • Data collection 2007-2010 • Participants • 13 outpatient services • 1,500 pre-therapy questionnaires • Attrition • Procedure • Self-ratings: SCL-90, QOLI (SRH, HAQ, CSQ) • Therapist assessments • Treatment methods: CBT, PDT, INT • Statistical analysis • Cohen’s d, RCSI
All patients where data at t1 is available N=1,498 Treatment starters n=1,294 (86.38%) Non-starters n=204 (13.62%) Remaining n=499 (33.31%) DO from treatment n=260 (17.36%) DO from data collection n=535 (35.71%) Completed therapies n=188 (12.55%) Ongoing therapies n=311 (20.76%) Other or unspecified therapy type n=8 Core group n=180 Complete data t1 SCL-90: n=177 QOLI: n=178 Complete data t2 SCL-90: n=175 QOLI: n=176 Attrition
Differences DO from treatment slightly younger DO from data collection more men slightly fewer previous psychiatric contacts Self-ratings – no significant differences Large groups Analysis of attrition All patients where data at t1 is available N=1,498 Treatment starters n=1,294 (86.38%) Non-starters n=204 (13.62%) Remaining n=499 (33.31%) DO from treatment n=260 (17.36%) DO from data collection n=535 (35.71%) Completed therapies n=188 (12.55%) Ongoing therapies n=311 (20.76%) Other or unspecified therapy type n=8 Core group n=180 Complete data t1 SCL-90: n=177 QOLI: n=178 Complete data t2 SCL-90: n=175 QOLI: n=176
Characteristics - by therapy type • Three groups (n=350) • CBT 63, PDT 206, INT 59 (22 other) • No significant differences regarding: • Gender (ca 70% female) • Self-rating • Significant differences: • Age (INT younger, M=24.7 yrs vs 32.2 & 32.3) • Level of education (INT less educated) • Occupation • Previous psychiatric contacts (CBT more)
All patients where data at t1 is available N=1,498 Treatment starters n=1,294 (86.38%) Non-starters n=204 (13.62%) Remaining n=499 (33.31%) DO from treatment n=260 (17.36%) DO from data collection n=535 (35.71%) Completed therapies n=188 (12.55%) Ongoing therapies n=311 (20.76%) Other or unspecified therapy type n=8 Core group n=180 Complete data t1 SCL-90: n=177 QOLI: n=178 Complete data t2 SCL-90: n=175 QOLI: n=176 Results - core group, effectiveness
Discussion • Psychotherapy in public health services is effective for patients who complete treatment • Cohen’s d 0.81 (GSI), 0.78 (QOLI) • Clinical improvement larger when measured by GSI (54.8%) compared to QOLI (21.3%) • Differences toward UK studies (CORE) • Cohen’s d 1.39, RCSI=58.3% • Different patients (primary care vs outpatient psychiatric services)
Discussion • The different therapy methods did not differ significantly in effectiveness • But effective for different aspects? • Symptom (SCL-90) vs Quality of Life (QOLI) • Systematic distribution of patients to treatments or therapists? • Dose-effect: longer treatment necessary for changes in quality of life? • Effects after termination?
Further research • Dropouts • Non-starters • Non-responders • Welcome to the poster session tonight!
Questions or comments? • Andrzej Werbartandrzej.werbart@sll.se • Lars Levinlars.levin@sll.se